Westwood Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Westwood Wealth Management's IBB Position: Q2 2026 in Review
Westwood Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 29% in Q2 2026, buying an estimated $258K and bringing the position to 6,600 shares worth $1.26M. The position accounts for 0.36% of the portfolio, ranked #25.
Westwood Wealth Management first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.42M in Q4 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Westwood Wealth Management held 6,600 shares of iShares Biotechnology ETF worth $1.26M as of Q2 2026.
- Westwood Wealth Management bought 1,500 iShares Biotechnology ETF shares in Q2 2026, an estimated $258K.
- iShares Biotechnology ETF made up 0.36% of Westwood Wealth Management's portfolio in Q2 2026, its #25 holding.
- Westwood Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
- Westwood Wealth Management's iShares Biotechnology ETF position peaked at $4.42M in Q4 2021.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Westwood Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.